Karnani Vikram 4

4 · Horizon Therapeutics Public Ltd Co · Filed Jan 6, 2021

Form 4

Period: 2021-01-04

SVP, Rheumatology Bus. Unit

Transactions

Award
Ordinary Shares
2021-01-05+65,088→ 191,366 total
Award
Restricted Stock Units (RSU)
2021-01-04+20,957→ 20,957 total
→ Ordinary Shares (20,957 underlying)
Exercise/Conversion
Restricted Stock Units (RSU)
2021-01-05−17,260→ 0 total
→ Ordinary Shares (17,260 underlying)
Exercise/Conversion
Restricted Stock Units (RSU)
2021-01-05−12,094→ 24,190 total
→ Ordinary Shares (12,094 underlying)
Exercise/Conversion
Ordinary Shares
2021-01-05+47,337→ 126,278 total
Tax Payment
Ordinary Shares
2021-01-05$73.28/sh−49,906$3,657,112→ 141,460 total
Exercise/Conversion
Restricted Stock Units (RSU)
2021-01-05−17,983→ 17,983 total
→ Ordinary Shares (17,983 underlying)

Footnotes (5)

[F1]Each RSU represents a contingent right to receive one ordinary share of the Issuer.
[F2]On January 5, 2018 and January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2021, the PSUs vested as to the number of shares reported above.
[F3]The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
[F4]The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
[F5]The RSU's vest 1/3rd annually on each anniversary of January 5, 2018.

Documents

1 file